Evidence map›Paper›PMID 24045948›Full record

Trial reportThe Journal of biological chemistry2013

Glycoepitopes of staphylococcal wall teichoic acid govern complement-mediated opsonophagocytosis via human serum antibody and mannose-binding lectin.

Kenji Kurokawa, Dong-Jun Jung, Jang-Hyun An, Katharina Fuchs, Yu-Jin Jeon, Na-Hyang Kim, Xuehua Li, Koichiro Tateishi, Ji Ae Park, Guoqing Xia and 5 more

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 72 citations in OpenAlex.

  1. Host-driven remodelling of theMicrobiology (Reading, England) · 2026
    Review
  2. Article
  3. A promisingClinical and experimental vaccine research · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. InvasiveScience advances · 2023
    Article
  9. Review
  10. Article
  11. A Simple and Rapid Methicillin-ResistantJournal of microbiology and biotechnology · 2023
    Article
  12. Extensive re-modelling of the cell wall during the development ofbioRxiv : the preprint server for biology · 2023
    Article
  13. Article
  14. Review
  15. Article
  16. DNA-derived nanostructures selectively capture gram-positive bacteria.Drug delivery and translational research · 2021
    Article
  17. Review
  18. Generation of glucosylatedRSC chemical biology · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 4 countries.

Kenji KurokawaFrom the National Research Laboratory of Defense Proteins, College of Pharmacy, Pusan National University, Pusan 609-735, Korea.
Dong-Jun Jung
Jang-Hyun An
Katharina Fuchs
Yu-Jin Jeon
Na-Hyang Kim
Xuehua Li
Koichiro Tateishi
Ji Ae Park
Guoqing Xia
Misao Matsushita
Kazue Takahashi
Hee-Ju Park
Andreas Peschel
Bok Luel Lee
Pusan National University · KRUniversity of Tübingen · DETokai University · JPHarvard University · USPusan National University Yangsan Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serum antibodies and mannose-binding lectin (MBL) are important host defense factors for host adaptive and innate immunity, respectively. Antibodies and MBL also initiate the classical and lectin complement pathways, respectively, leading to opsonophagocytosis. We have shown previously that Staphylococcus aureus wall teichoic acid (WTA), a cell wall glycopolymer consisting of ribitol phosphate substituted with α- or β-O-N-acetyl-d-glucosamine (GlcNAc) and d-alanine, is recognized by MBL and serum anti-WTA IgG. However, the exact antigenic determinants to which anti-WTA antibodies or MBL bind have not been determined. To answer this question, several S. aureus mutants, such as α-GlcNAc glycosyltransferase-deficient S. aureus ΔtarM, β-GlcNAc glycosyltransferase-deficient ΔtarS, and ΔtarMS double mutant cells, were prepared from a laboratory and a community-associated methicillin-resistant S. aureus strain. Here, we describe the unexpected finding that β-GlcNAc WTA-deficient ΔtarS mutant cells (which have intact α-GlcNAc) escape from anti-WTA antibody-mediated opsonophagocytosis, whereas α-GlcNAc WTA-deficient ΔtarM mutant cells (which have intact β-GlcNAc) are efficiently engulfed by human leukocytes via anti-WTA IgG. Likewise, MBL binding in S. aureus cells was lost in the ΔtarMS double mutant but not in either single mutant. When we determined the serum concentrations of the anti-α- or anti-β-GlcNAc-specific WTA IgGs, anti-β-GlcNAc WTA-IgG was dominant in pooled human IgG fractions and in the intact sera of healthy adults and infants. These data demonstrate the importance of the WTA sugar conformation for human innate and adaptive immunity against S. aureus infection.

Indexed as

Adaptive ImmunityAdultAntibodies, BacterialBacterial ProteinsCell WallEpitopesFemaleHumansImmunity, InnateImmunoglobulin GInfantInfant, NewbornLeukocytesMaleMannose-Binding LectinMutationAntibodies, BacterialBacterial ProteinsEpitopesImmunoglobulin GMannose-Binding LectinN-AcetylglucosaminyltransferasesTeichoic AcidsUDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferaseCell WallComplement SystemGram-positive BacteriaHost DefenseHost-Pathogen InteractionsInnate ImmunityS. aureus

Identifiers

PMID24045948
PMCPMC3829409
OpenAlexW2013289018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.